The claim stemmed from two recent cohort studies, one from South Korea and one from Italy.

Data in this new study shows that the 2024–2025 COVID-19 vaccines provide similar protection to the previous formulation. They were found to be most protective four weeks after vaccination, providing ...

The Food and Drug Administration signed off Wednesday on coronavirus vaccines for those considered higher risk, narrowing approval for shots once routinely provided to nearly all Americans. The agency ...

The release of Dr. Anthony Fauci's pandemic diaries has rekindled the debate over the origins of SARS-CoV-2. Here's how ...

As vaccine hesitancy and misinformation continue to challenge public confidence, 1 robust real-world data are essential in sustaining trust in vaccination programs. Cai and colleagues report that ...

2024-2025 COVID-19 vaccines reduced hospitalization risk by 40% against JN.1 lineage variants. COVID-19 is still a public threat and health concern. Between 2024 and 2025, an estimated 380,000 to ...

Walensky is a professor at Harvard Medical School and served as the 19th director of the Centers for Disease Control and Prevention. Once clinical trials showed that Covid-19 vaccines were safe and ...

A new broad-spectrum coronavirus antiviral, ASAP-0017445, has been nominated as a pre-clinical drug candidate by the Drugs for Neglected Diseases initiative (DNDi). The candidate is the first ...

Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. 3D renditions of three respiratory viruses: COVID-19, RSV, and ...

New York City's mostly indoor cats easily caught SARS-CoV-2 during the first wave of the COVID-19 epidemic—and most were asymptomatic and were likely infected by their owners, according to a new study ...